查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1434995

光化性角化症治療市場：按疾病類型、治療方法、最終用戶分類 - 全球預測 2024-2030

Actinic Keratosis Treatment Market by Disease Type (Clinical AK, Subclinical AK), Treatment (Medication, Surgery), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

光化性角化症治療市場規模預估2023年為62.1億美元，2024年達64.8億美元，預估2030年將達83.8億美元，複合年成長率為4.37%。

光化性角化症治療的全球市場

主要市場統計
基準年[2023] 62.1億美元
預測年份 [2024] 64.8億美元
預測年份 [2030] 83.8億美元
複合年成長率（%） 4.37%
光化性角化症治療市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估光化性角化病治療市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對光化性角化病治療市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-光化性角化症治療市場的市場規模和預測是多少？

2-在光化性角化症治療市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3-光化性角化症治療市場的技術趨勢和法律規範是什麼？

4-光化性角化症治療市場主要供應商的市場佔有率是多少？

5-進入光化性角化症治療市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 光化性角化症和皮膚癌病例數增加
      • 戶外運動偏好的興起與發展
      • 提高消費者對皮膚病的認知
    • 抑制因素
      • 與光化性角化症治療相關的不良健康影響
    • 機會
      • 光化性角化症的外用藥物和治療方法的核准激增
      • 動態療法治療光化性角化症和非黑色素瘤皮膚癌持續進展
    • 任務
      • 光化性角化症治療缺乏標準化
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章光化性角化症治療市場：依疾病類型

  • 臨床AK
  • 無症狀性AK

第7章光化性角化症治療市場（依治療）

  • 藥品
    • 藥膏或凝膠
      • Fluorouracil
      • 咪喹莫特
      • 巨大戟二甲酚甲酸酯或雙氯芬酸鈉
  • 外科手術
    • 冷凍療法
    • 刮宮術
    • 雷射治療
    • 動態療法

第8章光化性角化症治療市場：依最終用戶分類

  • 癌症治療中心
  • 居家護理
  • 醫院
  • 雷射治療中心
  • 私人皮膚科診所
  • 水療和恢復中心

第9章北美及南美光化性角化症治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區光化性角化症治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的光化性角化病治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第13章競爭產品組合

  • 主要公司簡介
    • 3M Company
    • Accord Healthcare, Inc.
    • AdipoGen Life Sciences
    • Almirall, SA
    • Athenex, Inc.
    • Bausch Health Companies, Inc.
    • Biofrontera AG
    • Enzo Life Sciences Inc.
    • Fresenius Kabi
    • Galderma SA
    • Glenmark Pharmaceuticals Limited
    • Hill Dermaceuticals, Inc.
    • LEO Pharma A/S.
    • Merck KGaA
    • Novartis AG
    • Perrigo Company PLC
    • Sagent Pharmaceuticals, Inc.
    • Spear Dermatology Products, Inc.
    • Stanford Chemicals Company
    • Strides Pharma Science Limited
    • Sun Pharmaceutical Industries Ltd.
    • Taj Pharmaceuticals Ltd.
    • Taro Pharmaceutical Industries Ltd.
    • Viatris, Inc.
    • Xiromed LLC
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-B16853776D0C

[185 Pages Report] The Actinic Keratosis Treatment Market size was estimated at USD 6.21 billion in 2023 and expected to reach USD 6.48 billion in 2024, at a CAGR 4.37% to reach USD 8.38 billion by 2030.

Global Actinic Keratosis Treatment Market

KEY MARKET STATISTICS
Base Year [2023] USD 6.21 billion
Estimated Year [2024] USD 6.48 billion
Forecast Year [2030] USD 8.38 billion
CAGR (%) 4.37%
Actinic Keratosis Treatment Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Actinic Keratosis Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Actinic Keratosis Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Actinic Keratosis Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Accord Healthcare, Inc., AdipoGen Life Sciences, Almirall, S.A., Athenex, Inc., Bausch Health Companies, Inc., Biofrontera AG, Enzo Life Sciences Inc., Fresenius Kabi, Galderma SA, Glenmark Pharmaceuticals Limited, Hill Dermaceuticals, Inc., LEO Pharma A/S., Merck KGaA, Novartis AG, Perrigo Company PLC, Sagent Pharmaceuticals, Inc., Spear Dermatology Products, Inc., Stanford Chemicals Company, Strides Pharma Science Limited, Sun Pharmaceutical Industries Ltd., Taj Pharmaceuticals Ltd., Taro Pharmaceutical Industries Ltd., Viatris, Inc., and Xiromed LLC.

Market Segmentation & Coverage

This research report categorizes the Actinic Keratosis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Disease Type
    • Clinical AK
    • Subclinical AK
  • Treatment
    • Medication
      • Medicated Cream or Gel
        • Fluorouracil
        • Imiquimod
        • Ingenol Mebutate or Diclofenac
    • Surgery
      • Cryotherapy
      • Curettage
      • Laser Therapy
      • Photodynamic Therapy
  • End-User
    • Cancer Treatment Centers
    • Homecare
    • Hospitals
    • Laser Therapy Centers
    • Private Dermatology Clinics
    • Spas & Rejuvenation Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Actinic Keratosis Treatment Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Actinic Keratosis Treatment Market?

3. What are the technology trends and regulatory frameworks in the Actinic Keratosis Treatment Market?

4. What is the market share of the leading vendors in the Actinic Keratosis Treatment Market?

5. Which modes and strategic moves are suitable for entering the Actinic Keratosis Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Actinic Keratosis Treatment Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of cases of actinic keratosis and skin cancer
      • 5.1.1.2. Growing preference and development of outdoor sports activities
      • 5.1.1.3. Accelerated awareness among consumers for dermatological disease
    • 5.1.2. Restraints
      • 5.1.2.1. Associated adverse health impacts of actinic keratosis treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in approvals of topical agents and treatment for actinic keratosis
      • 5.1.3.2. Ongoing advances in photodynamic therapy for the treatment of actinic keratosis and nonmelanoma skin cancer
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardizations for actinic keratosis treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Actinic Keratosis Treatment Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Clinical AK
  • 6.3. Subclinical AK

7. Actinic Keratosis Treatment Market, by Treatment

  • 7.1. Introduction
  • 7.2. Medication
    • 7.3.1. Medicated Cream or Gel
      • 7.3.2.1. Fluorouracil
      • 7.3.2.2. Imiquimod
      • 7.3.2.3. Ingenol Mebutate or Diclofenac
  • 7.3. Surgery
    • 7.4.1. Cryotherapy
    • 7.4.2. Curettage
    • 7.4.3. Laser Therapy
    • 7.4.4. Photodynamic Therapy

8. Actinic Keratosis Treatment Market, by End-User

  • 8.1. Introduction
  • 8.2. Cancer Treatment Centers
  • 8.3. Homecare
  • 8.4. Hospitals
  • 8.5. Laser Therapy Centers
  • 8.6. Private Dermatology Clinics
  • 8.7. Spas & Rejuvenation Centers

9. Americas Actinic Keratosis Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Actinic Keratosis Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Actinic Keratosis Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. 3M Company
    • 13.1.2. Accord Healthcare, Inc.
    • 13.1.3. AdipoGen Life Sciences
    • 13.1.4. Almirall, S.A.
    • 13.1.5. Athenex, Inc.
    • 13.1.6. Bausch Health Companies, Inc.
    • 13.1.7. Biofrontera AG
    • 13.1.8. Enzo Life Sciences Inc.
    • 13.1.9. Fresenius Kabi
    • 13.1.10. Galderma SA
    • 13.1.11. Glenmark Pharmaceuticals Limited
    • 13.1.12. Hill Dermaceuticals, Inc.
    • 13.1.13. LEO Pharma A/S.
    • 13.1.14. Merck KGaA
    • 13.1.15. Novartis AG
    • 13.1.16. Perrigo Company PLC
    • 13.1.17. Sagent Pharmaceuticals, Inc.
    • 13.1.18. Spear Dermatology Products, Inc.
    • 13.1.19. Stanford Chemicals Company
    • 13.1.20. Strides Pharma Science Limited
    • 13.1.21. Sun Pharmaceutical Industries Ltd.
    • 13.1.22. Taj Pharmaceuticals Ltd.
    • 13.1.23. Taro Pharmaceutical Industries Ltd.
    • 13.1.24. Viatris, Inc.
    • 13.1.25. Xiromed LLC
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ACTINIC KERATOSIS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ACTINIC KERATOSIS TREATMENT MARKET DYNAMICS
  • FIGURE 7. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 10. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ACTINIC KERATOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ACTINIC KERATOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ACTINIC KERATOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CLINICAL AK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SUBCLINICAL AK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 9. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 11. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 13. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY FLUOROURACIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY IMIQUIMOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY INGENOL MEBUTATE OR DICLOFENAC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 18. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CRYOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CURETTAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CANCER TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY LASER THERAPY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRIVATE DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SPAS & REJUVENATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. ACTINIC KERATOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 280. ACTINIC KERATOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 281. ACTINIC KERATOSIS TREATMENT MARKET LICENSE & PRICING